Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560791 · ClinicalTrials.gov registry record
A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence
A clinical trial of Non-Small Cell Lung Cancer, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- 7,659
- Enrollment target
- 1
- Study location
NCT03560791: Completed study of Non-Small Cell Lung Cancer, sponsored by St Elizabeth Healthcare.
NCT03560791 is a study of Non-Small Cell Lung Cancer that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 7,659 participants, above the 636-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (1104% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560791, a study of Non-Small Cell Lung Cancer, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- 7,659 participants
- Enrollment target
- 1
- Study location
Study Summary
An analysis of Low-Dose Cat Scan(LDCT) Screenings for Lung Cancer completed within the St. Elizabeth system from January 2015 until December 2019. The study investigator, or designee(s), will retrospectively review patient encounters, collecting data related to LDCT referrals and completions. Data analysis will focus on the subsequent imaging, procedures, reviews at The Nodule Review Board and Lung Cancers diagnosed as a result of the LDCT.
Primary Outcome
When the patient completed the LDCT(s)
Conditions Studied
Study Locations (1)
Kentucky
- St. Elizabeth Healthcare - Edgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,659 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2023-03-06 |
What the finished NCT03560791 record still lists
NCT03560791 is an observational study that tracks outcomes without assigning an intervention. Its 7,659 participants enrollment target places it among the larger protocols in the corpus, above the 636-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (1104% higher).
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03560791 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03560791 about?
NCT03560791 is a clinical study titled "A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence". An analysis of Low-Dose Cat Scan(LDCT) Screenings for Lung Cancer completed within the St. Elizabeth system from January 2015 until December 2019. The study investigator, or designee(s), will retrospectively review patient encounters, collecting data related to LDCT referrals and completions. Data a...
What is the current status of trial NCT03560791?
This trial is currently completed. The enrollment target is 7,659 participants. The study started on 2018-04-06. Estimated completion is 2023-03-06.
What conditions does trial NCT03560791 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
Who is sponsoring clinical trial NCT03560791?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03560791 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03560791's enrollment target sits among peer trials
7,659 3rd of 454 higher than 452 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI